Novel non-peptidic opioid compounds with immunopotentiating effects.
Riley
M E
ME
Department of Biomedical and Therapeutic Sciences University of Illinois College of Medicine, Peoria, USA.
Ananthan
S
S
Weber
R J
RJ
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D001597:Benzylidene Compounds / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D008297:Male; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000494:pharmacology; D009294:Narcotics / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D011916:Rats, Inbred F344; D013004:Somatostatin / Q000031:analogs & derivatives / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D000276:Adjuvants, Immunologic; D001597:Benzylidene Compounds; C114628:NTI compound; D009294:Narcotics; C049352:phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide; C077358:7-benzylidenenaltrexone; D013004:Somatostatin; D009271:Naltrexone